p53 and FHIT mutations and microsatellite alterations in malignancy-associated pleural effusion
- 30 April 2004
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 44 (1) , 33-42
- https://doi.org/10.1016/j.lungcan.2003.10.007
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Molecular epidemiology of human cancer risk: gene-environment interactions andp53 mutation spectrum in human lung cancerThe Journal of Pathology, 1999
- Elevated Level of Carcinoembryonic Antigen in Nonmalignant Pleural EffusionsChest, 1997
- Preferential Formation of Benzo[ a ]pyrene Adducts at Lung Cancer Mutational Hotspots in P53Science, 1996
- CLINICAL IMPLICATIONS OF THE p53 GENEAnnual Review of Medicine, 1996
- Diagnosis and management of malignant pleural effusionsThe American Journal of Surgery, 1995
- Diagnosis of Pleural EffusionsChest, 1995
- Interleukin 1 β synergises with interleukin 2 in the outgrowth of autologous tumour-reactive CD8+ effectorsBritish Journal of Cancer, 1994
- Correlation of loss of heterozygosity at 11 p with tumour progression and survival in non-small cell lung cancerGenes, Chromosomes and Cancer, 1994
- Comparison of Needle Biopsy With Cytologic Analysis for the Evaluation of Pleural Effusion: Analysis of 414 CasesMayo Clinic Proceedings, 1985
- Specific Chromosome Defect Associated with Human Small-Cell Lung Cancer: Deletion 3p(14-23)Science, 1982